News - TH-302

Filter

Current filters:

TH-302

Popular Filters

Merck Serono initiation of TH-302 Ph III trial triggers $30 million milestone for Threshold

29-01-2013

Merck Serono, the pharma division of Germany's Merck KGaA (MRK: DE), has initiated the global Phase III…

FinancialMerck KGaAMerck SeronoOncologyPharmaceuticalResearchTH-302Threshold Pharmaceuticals

Back to top